While the antitumor efficacy–FcRn relationship (Figure 6D) is derived from only three tumor mouse model studies and needs to be confirmed from additional tumor models, the relationship may be explained by the HSA cellular recycling mechanism via FcRn [39,40]. This evidence concerns the gene ALB and neoplasm.